Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 36651 - 36675 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	BTN3A2	11118	upregulated	entinostat results in increased expression of BTN3A2 mRNA	6p22.2	A21035
Entinostat	Investigational	BVES	11149	upregulated	entinostat results in increased expression of BVES mRNA	6q21	A21035
Entinostat	Investigational	BVES-AS1	154442	upregulated	entinostat results in increased expression of BVES-AS1 mRNA	6q21	A21035
Entinostat	Investigational	C1QTNF2	114898	upregulated	entinostat results in increased expression of C1QTNF2 mRNA	5q33.3	A21037 A21035
Entinostat	Investigational	C3	718	upregulated	entinostat results in increased expression of C3 mRNA	19p13.3	A21037
Entinostat	Investigational	C5	727	downregulated	entinostat results in decreased expression of C5 mRNA	9q33.2	A21037
Entinostat	Investigational	CA12	771	upregulated	entinostat results in increased expression of CA12 mRNA	15q22.2	A21037
Entinostat	Investigational	CA13	377677	upregulated	entinostat results in increased expression of CA13 mRNA	8q21.2	A21037
Entinostat	Investigational	CA4	762	upregulated	entinostat results in increased expression of CA4 mRNA	17q23.1	A21035
Entinostat	Investigational	CACNA1A	773	upregulated	entinostat results in increased expression of CACNA1A mRNA	19p13.13	A21035
Entinostat	Investigational	CACNA1G	8913	upregulated	entinostat results in increased expression of CACNA1G mRNA	17q21.33	A21035
Entinostat	Investigational	CACNA2D1	781	downregulated	entinostat results in decreased expression of CACNA2D1 mRNA	7q21.11	A21035
Entinostat	Investigational	CACNA2D1	781	upregulated	entinostat results in increased expression of CACNA2D1 mRNA	7q21.11	A21037
Entinostat	Investigational	CACNG8	59283	upregulated	entinostat results in increased expression of CACNG8 mRNA	19q13.42	A21035
Entinostat	Investigational	CADM4	199731	downregulated	entinostat results in decreased expression of CADM4 mRNA	19q13.31	A21037
Entinostat	Investigational	CALB1	793	upregulated	entinostat results in increased expression of CALB1 mRNA	8q21.3	A21037
Entinostat	Investigational	CALCA	796	upregulated	entinostat results in increased expression of CALCA mRNA	11p15.2	A21037
Entinostat	Investigational	CALCRL	10203	upregulated	entinostat results in increased expression of CALCRL mRNA	2q32.1	A21035
Entinostat	Investigational	CALML4	91860	downregulated	entinostat results in decreased expression of CALML4 mRNA	15q23	A21037
Entinostat	Investigational	CALN1	83698	upregulated	entinostat results in increased expression of CALN1 mRNA	7q11.22	A21035
Entinostat	Investigational	CAMK2N1	55450	downregulated	entinostat results in decreased expression of CAMK2N1 mRNA	1p36.12	A21037
Entinostat	Investigational	CAND1	55832	downregulated	entinostat results in decreased expression of CAND1 mRNA	12q14.3-q15	A21037
Entinostat	Investigational	CAP2	10486	downregulated	entinostat results in decreased expression of CAP2 mRNA	6p22.3	A21037
Entinostat	Investigational	CAPG	822	upregulated	entinostat results in increased expression of CAPG mRNA	2p11.2	A21035
Entinostat	Investigational	CAPN6	827	downregulated	entinostat results in decreased expression of CAPN6 mRNA	Xq23	A21037

Displaying entries 36651 - 36675 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability